Revenue
$8,000
0.0% YoY
Net Income
-$32.1M
▼ 7.6% YoY
EPS
$-0.86
▲ 9.5% YoY
Cash
$5.3M
▼ 37.7% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Smalling Ralph Head of Regulatory | Sell | Jun 3, 2026 | 192 | $2.93 | $563 | Form 4 ↗ |
Thomas John | Sell | Jun 1, 2026 | 10.0K | $2.98 | $30K | Form 4 ↗ |
Yu Yong Chief Scientific Officer | Sell | May 11, 2026 | 605 | $2.97 | $2K | Form 4 ↗ |
Cappello Joseph Chief Technical Officer | Sell | May 11, 2026 | 605 | $2.97 | $2K | Form 4 ↗ |
Zindrick Thomas President and CEO | Sell | May 11, 2026 | 2.8K | $2.94 | $8K | Form 4 ↗ |
Smalling Ralph Head of Regulatory | Sell | May 11, 2026 | 270 | $2.98 | $804 | Form 4 ↗ |
Smalling Ralph Head of Regulatory | Sell | Mar 25, 2026 | 240 | $2.51 | $602 | Form 4 ↗ |
Smalling Ralph Head of Regulatory | Sell | Mar 24, 2026 | 345 | $2.42 | $835 | Form 4 ↗ |
Cappello Joseph Chief Technical Officer | Sell | Mar 24, 2026 | 906 | $2.42 | $2K | Form 4 ↗ |
Yu Yong SVP, Clinical Development | Sell | Mar 24, 2026 | 906 | $2.42 | $2K | Form 4 ↗ |
Zindrick Thomas President and CEO | Sell | Mar 24, 2026 | 3.6K | $2.42 | $9K | Form 4 ↗ |